Who are Fluoxétine and Budésonide's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/fluox-tine-and-bud-sonide.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Fluoxétine and Budésonide — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fluoxétine and Budésonide (Fluoxétine and Budésonide) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: SSRI, corticosteroid. Area: Psychiatry, Respiratory.

phase 2 SSRI, corticosteroid Serotonin transporter, glucocorticoid receptor Psychiatry, Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Fluoxétine and Budésonide (Fluoxétine and Budésonide) — ANRS, Emerging Infectious Diseases. Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) and budesonide is a corticosteroid.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Fluoxétine and Budésonide TARGET	Fluoxétine and Budésonide	ANRS, Emerging Infectious Diseases	phase 2	SSRI, corticosteroid	Serotonin transporter, glucocorticoid receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (SSRI, corticosteroid class)

ANRS, Emerging Infectious Diseases · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Fluoxétine and Budésonide — Competitive Intelligence Brief. https://druglandscape.com/ci/fluox-tine-and-bud-sonide. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab